• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 389

Steviol glycosides with stevioside as the principal component

Intended Use: General-purpose sweetener in foods, excluding meat and poultry products, at levels determined by current good manufacturing practices, as well as use as a table top sweetener
Basis: Scientific procedures
Notifier: Chengdu Wagott Pharmaceutical
Notifier Address: Company facility: 5/F, A Building, Tianhe Incubator, Hi-tech Incubating Park, Tianfu Ave.,
Chengdu, Sichuan 610041 CHINA
Date of filing: Jul 26, 2011
GRAS Notice (releasable information): GRN 389 (in PDF)
Date of closure: Jan 18, 2012
FDA's Letter: FDA has no questions